In response to Grivas et al

• Ingeborg van den Berg,
• Mark H.F. Savenije,
• Frederik R. Teunissen,
• Sandrine M.G. van de Pol,
• Marnix J.A. Rasing,
• Harm H.E. van Melick,
• Wyger M. Brink,
• Johannes C.J. de Boer,
• Cornelis A.T. van den Berg,
• Jochem R.N. van der Voort van Zyp

Affiliations

Ingeborg van den Berg

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Urology, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands; Corresponding author at: Department of Radiation Oncology, University Medical Center Utrecht. Heidelberglaan 100, 3584 CZ Utrecht, The Netherlands.

Mark H.F. Savenije

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Frederik R. Teunissen

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Sandrine M.G. van de Pol

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Marnix J.A. Rasing

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Harm H.E. van Melick

Department of Urology, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands

Wyger M. Brink

Magnetic Detection and Imaging Group, Technical Medical Centre, University of Twente, Enschede, The Netherlands

Johannes C.J. de Boer

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Cornelis A.T. van den Berg

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Jochem R.N. van der Voort van Zyp

Department of Radiation Oncology, Division of Imaging & Oncology, University Medical Center Utrecht, Utrecht, The Netherlands